• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Turns Lower; EchoStar Shares Plunge

    11/6/23 2:28:23 PM ET
    $BVH
    $CREV
    $DBGI
    $DISH
    Real Estate
    Finance
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $BVH alert in real time by email

    U.S. stocks turned lower toward the end of trading, with the Dow Jones falling around 50 points on Monday

    The Dow traded down 0.16% to 34,007.81 while the NASDAQ fell 0.08% to 13,467.42. The S&P 500 also fell, dropping, 0.13% to 4,352.49.

    Check This Out: Top 5 Health Care Stocks That May Fall Off A Cliff This Month

     

    Leading and Lagging Sectors

     

    Health care shares jumped by 0.7% on Monday.

    In trading on Monday, real estate shares fell by 1.7%.

     

    Top Headline

     

    Kosmos Energy Ltd (NYSE:KOS) reported better-than-expected earnings for its third quarter on Monday.

    Kosmos Energy reported third-quarter (Q3) 2023 revenue of $526.5 million, beating the consensus of $457.4 million. Adjusted EPS of 26 cents, surpassing the consensus of $0.21.

    For FY23, the company now expects capital expenditure of ~$800 million (vs. $700 million - $750 million earlier) and production of ~63,000 boe per day (vs. 65,000 - 69,000 boe per day prior).

     

    Equities Trading UP

     

    Carbon Revolution Public Limited (NASDAQ:CREV) shares shot up 204% to $89.00 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.

    Shares of Bluegreen Vacations Holding Corporation (NYSE:BVH) got a boost, shooting 106% to $73.00 after the company announced it would be acquired by Hilton Grand Vacations at $75 per share.

    Digital Brands Group, Inc. (NASDAQ:DBGI) shares were also up, gaining 22% to $5.35 after the company announced a review of strategic alternatives.

     

    Equities Trading DOWN

     

    MoonLake Immunotherapeutics (NASDAQ:MLTX) shares dropped 24% to $39.06 after the company announced results of its phase 2 study treating active Psoriatic Arthritis.

    Shares of DISH Network Corporation (NASDAQ:DISH) were down 22% to $4.2701 after the company reported third-quarter results. On Nov. 3, 2023, W. Erik Carlson notified DISH that he intends to resign as the CEO effective Nov. 12, 2023.

    EchoStar Corporation (NASDAQ:SATS) was down, falling 21% to $12.14 after the company reported worse-than-expected third-quarter sales.

    Also Check This Out: Bitcoin Falls Below $35,000; Neo, MultiversX Among Top Losers

     

    Commodities

     

    In commodity news, oil traded up 1.5% to $81.69 while gold traded down 0.4% at $1,990.70.

    Silver traded down 0.3% to $23.215 on Monday while copper rose 1% to $3.7165.

     

    Euro zone

     

    European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.16%, London’s FTSE 100 rose 0.01% while Spain’s IBEX 35 Index fell 0.56% The German DAX fell 0.35% French CAC 40 fell 0.48%, while Italy’s FTSE MIB Index fell 0.29%.

    Factory orders in Germany increased 0.2% month-over-month in September compared to a revised 1.9% increase in August. The HCOB Spain Composite PMI edged lower to 50 in October from 50.1 in the earlier month.

     

    Asia Pacific Markets

     

    Asian markets closed higher on Monday, with Japan’s Nikkei 225 gaining 2.37%, Hong Kong’s Hang Seng Index gaining 1.71% and China’s Shanghai Composite Index gaining 0.91%. India’s S&P BSE Sensex, meanwhile, rose around 0.7%.

    The au Jibun Bank Japan services PMI fell to 51.6 in October versus a final reading of 53.8 in September, while composite PMI slipped to 50.5 from a final level of 52.1 in September.

     

    Economics

     

    There were no major US economic releases Monday.

    Now Read This: These 3 Defensive Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

    Get the next $BVH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BVH
    $CREV
    $DBGI
    $DISH

    CompanyDatePrice TargetRatingAnalyst
    MoonLake Immunotherapeutics
    $MLTX
    1/15/2026$10.00Neutral → Sell
    Goldman
    MoonLake Immunotherapeutics
    $MLTX
    1/9/2026$24.00Neutral → Buy
    BTIG Research
    EchoStar Corporation
    $SATS
    12/10/2025$110.00Equal-Weight → Overweight
    Morgan Stanley
    Kosmos Energy Ltd.
    $KOS
    12/5/2025$3.50Buy → Accumulate
    Johnson Rice
    Kosmos Energy Ltd.
    $KOS
    12/5/2025$1.00Buy → Underperform
    BofA Securities
    Kosmos Energy Ltd.
    $KOS
    11/11/2025$1.75Equal-Weight
    Stephens
    MoonLake Immunotherapeutics
    $MLTX
    11/3/2025$30.00Neutral → Buy
    H.C. Wainwright
    Kosmos Energy Ltd.
    $KOS
    10/24/2025$4.00Buy
    Clarksons Platou
    More analyst ratings

    $BVH
    $CREV
    $DBGI
    $DISH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brokaw George R bought $68,070 worth of shares (1,000 units at $68.07), increasing direct ownership by 57% to 2,754 units (SEC Form 4)

    4 - EchoStar CORP (0001415404) (Issuer)

    11/20/25 4:40:47 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    Chief Financial Officer Bodenstedt Matthias bought $98,808 worth of Class A ordinary shares (10,870 units at $9.09), increasing direct ownership by 2% to 627,536 units (SEC Form 4)

    4 - MoonLake Immunotherapeutics (0001821586) (Issuer)

    10/9/25 9:01:51 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN Ergen Charles W bought $43,499,994 worth of shares (1,551,355 units at $28.04) (SEC Form 4)

    4 - EchoStar CORP (0001415404) (Issuer)

    11/14/24 5:15:44 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    $BVH
    $CREV
    $DBGI
    $DISH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MoonLake Immunotherapeutics downgraded by Goldman with a new price target

    Goldman downgraded MoonLake Immunotherapeutics from Neutral to Sell and set a new price target of $10.00

    1/15/26 8:33:55 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MoonLake Immunotherapeutics upgraded by BTIG Research with a new price target

    BTIG Research upgraded MoonLake Immunotherapeutics from Neutral to Buy and set a new price target of $24.00

    1/9/26 8:33:00 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EchoStar upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded EchoStar from Equal-Weight to Overweight and set a new price target of $110.00

    12/10/25 8:13:05 AM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    $BVH
    $CREV
    $DBGI
    $DISH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by EchoStar Corporation

    SCHEDULE 13G/A - EchoStar CORP (0001415404) (Subject)

    2/6/26 1:11:50 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    SEC Form 6-K filed by Carbon Revolution Public Limited

    6-K - Carbon Revolution Public Ltd Co (0001960208) (Filer)

    2/6/26 9:15:06 AM ET
    $CREV
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by EchoStar Corporation

    SCHEDULE 13G/A - EchoStar CORP (0001415404) (Subject)

    2/5/26 1:23:13 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    $BVH
    $CREV
    $DBGI
    $DISH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

    Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene's clinical organization and drive completion of the Phase 2b ADAPTIVE trial in atopic dermatitis Will expand Phase 2b trial footprint with planned international sites including in the UK and Europe SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (NASDAQ:IMA, "Imagene, " or the "Company")), today announced the appointment of Dr. Ben Porter-Brown, a seasoned autoimmune and inflammatory drug developer with experience in the OX40 receptor-ligand (OX40-OX40L) inhibition field, as its Chief Medical Officer. He will be fo

    2/10/26 7:00:00 AM ET
    $IMA
    $MLTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Carbon Revolution Announces Receipt of Delisting Determination Letter from Nasdaq

    GEELONG, Australia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Carbon Revolution plc (NASDAQ:CREV) (the "Company"), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that it has received a notification letter (the "Letter") from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") indicating that the Nasdaq Hearing Panel (the "Panel") has decided to deny the Company's request for continued listing on Nasdaq, based upon the Company's non-compliance with Listing Rule 5550(b), Nasdaq's minimum shareholders' equity rule (the "Equity Rule") and the Company's non-compliance

    2/6/26 9:15:00 AM ET
    $CREV
    Auto Parts:O.E.M.
    Consumer Discretionary

    MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

    The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positive results from the Phase 2 LEDA trialThe upcoming Phase 3 program will therefore be expected to benefit from earlier and more frequent interactions with the FDA under the Fast Track program, potentially enabling a more efficient development pathway This regulatory decision follows the recent clear guidance from the FDA, in which the Company confirmed its clinical evidence strategy for the planned submission of a Biologic License Application (BLA) in H2 2026 for SLK in hidradenitis suppurativa (H

    2/2/26 8:00:00 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BVH
    $CREV
    $DBGI
    $DISH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP & Chief Accounting Officer Glass Ronald W. was granted 7,732 shares and sold $31,125 worth of shares (22,598 units at $1.38), decreasing direct ownership by 4% to 339,632 units (SEC Form 4)

    4 - Kosmos Energy Ltd. (0001509991) (Issuer)

    2/5/26 5:13:02 PM ET
    $KOS
    Oil & Gas Production
    Energy

    SVP and General Counsel Marion Josh R. was granted 7,661 shares and sold $31,592 worth of shares (22,940 units at $1.38), decreasing direct ownership by 7% to 194,125 units (SEC Form 4)

    4 - Kosmos Energy Ltd. (0001509991) (Issuer)

    2/5/26 5:12:36 PM ET
    $KOS
    Oil & Gas Production
    Energy

    SVP and CFO Shah Nealesh D. sold $109,634 worth of shares (79,124 units at $1.39) and was granted 65,567 shares, decreasing direct ownership by 0.79% to 1,705,167 units (SEC Form 4)

    4 - Kosmos Energy Ltd. (0001509991) (Issuer)

    2/5/26 5:12:05 PM ET
    $KOS
    Oil & Gas Production
    Energy

    $BVH
    $CREV
    $DBGI
    $DISH
    Leadership Updates

    Live Leadership Updates

    View All

    ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

    Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene's clinical organization and drive completion of the Phase 2b ADAPTIVE trial in atopic dermatitis Will expand Phase 2b trial footprint with planned international sites including in the UK and Europe SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (NASDAQ:IMA, "Imagene, " or the "Company")), today announced the appointment of Dr. Ben Porter-Brown, a seasoned autoimmune and inflammatory drug developer with experience in the OX40 receptor-ligand (OX40-OX40L) inhibition field, as its Chief Medical Officer. He will be fo

    2/10/26 7:00:00 AM ET
    $IMA
    $MLTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Inseego Strengthens Board of Directors with Experienced Operational Leaders in Carrier, AI, and SaaS

    SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (NASDAQ:INSG), a global leader in 5G mobile broadband and 5G fixed wireless access (FWA) solutions, announced today that Nabil Bukhari and Stephen Bye are joining its Board of Directors. Both operating executives bring extensive experience in wireless networking, SaaS, and AI, combined with a strong record of driving transformation and go-to-market execution. Their backgrounds in product innovation, platform growth, and business model monetization align directly with Inseego's strategy to expand its leadership in enterprise connectivity and grow into new markets. "Nabil and Stephen are exceptional executives and operational leader

    11/3/25 8:00:00 AM ET
    $EXTR
    $INSG
    $SATS
    Computer Communications Equipment
    Telecommunications
    Telecommunications Equipment
    Consumer Discretionary

    Boost Mobile Adds moto g stylus to Its 2025 Device Lineup, Merging Creativity With Connectivity

    Get the new moto g stylus for FREE or as low as $49.99 with Boost Mobile's Back-to-School promotions. LITTLETON, Colo., July 8, 2025 /PRNewswire/ -- Boost Mobile is expanding its 2025 Android device portfolio with the launch of the new moto g stylus from Motorola – delivering a powerful blend of creativity, productivity and entertainment at a price point that's hard to beat. New customers who switch to Boost Mobile and port their number can get the moto g stylus FREE when they activate on a $50 or $60 rate plan. And for a limited time, existing customers can purchase or upgrad

    7/8/25 10:03:00 AM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    $BVH
    $CREV
    $DBGI
    $DISH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by EchoStar Corporation

    SC 13D/A - EchoStar CORP (0001415404) (Subject)

    11/14/24 4:15:27 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    SEC Form SC 13G filed by EchoStar Corporation

    SC 13G - EchoStar CORP (0001415404) (Subject)

    11/13/24 1:16:56 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by EchoStar Corporation

    SC 13G/A - EchoStar CORP (0001415404) (Subject)

    11/12/24 2:32:53 PM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    $BVH
    $CREV
    $DBGI
    $DISH
    Financials

    Live finance-specific insights

    View All

    Kosmos Energy to Host Fourth Quarter 2025 Results and Webcast on March 2, 2026

    Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its fourth quarter 2025 results: Earnings Release: Monday, March 2, 2026, pre-UK market open via Business Wire, Regulatory News Service, and the Company's website at www.kosmosenergy.com. Conference Call: Monday, March 2, 2026, at 11:00 a.m. ET. The call will be available via telephone and webcast. Dial-in telephone numbers: Toll Free: 1-800-715-9871 Toll/International: 1-646-307-1963 UK Toll Free: 0800 260 6466 Webcast: investors.kosmosenergy.com Webcast Conference Call Replay: A replay of the webcast will be available at investors.kosmosenergy.com for approximately 90 days following the event. About

    2/2/26 2:00:00 AM ET
    $KOS
    Oil & Gas Production
    Energy

    EchoStar Announces Financial Results for the Three and Nine Months Ended September 30, 2025

    EchoStar Capital Division Announced to Spearhead Future Growth Opportunities Wireless: Net subscriber growth (+223K), improved churn (2.86%, an improvement of 13 basis points year-over-year), improved average revenue per user (ARPU) (2.6% year-over-year) and continued to have the highest prepaid ARPU in the industry.Pay-TV: DISH TV churn (1.33%) is at a historic low for the third quarter, growth in ARPU (+1% year-over-year) and continued increase in viewership engagement (hours/viewer). Sling TV added approximately 159K subscribers in the third quarter.Broadband & Satellite Services: Enterprise order backlog (future revenues) of $1.5B, primarily through gaining share in the aviation sector.E

    11/6/25 6:30:00 AM ET
    $SATS
    Telecommunications Equipment
    Consumer Discretionary

    MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

    Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to provide runway into the second half of 2027Reported results of its Phase 2 LEDA clinical trial in Palmoplantar Pustulosis (PPP) where sonelokimab (SLK) demonstrated clinically meaningful and statistically significant benefitReported an interim analysis of the long-term data from the VELA-1 and VELA-2 clinical trials in adults with Hidradenitis Suppurativa (HS), as well as an interim analysis of its VELA-TEEN clinical trial in adolescent HS, demonstrating the potential and competitive benefit of SL

    11/5/25 7:00:00 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care